MedPath

福建南少林药业有限公司

Ownership
-
Established
1996-12-30
Employees
-
Market Cap
-
Website
www.fjnsl.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

111

NMPA:111

Drug Approvals

Compound Amino Acid Injection(18AA)

Product Name
复方氨基酸注射液(18AA)
Approval Number
国药准字H20033381
Approval Date
May 10, 2024
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H20073126
Approval Date
Jan 16, 2024
NMPA

Dexamethasone Sodium Phosphate Injection

Product Name
地塞米松磷酸钠注射液
Approval Number
国药准字H35020009
Approval Date
Jan 3, 2024
NMPA

Dexamethasone Sodium Phosphate Injection

Product Name
地塞米松磷酸钠注射液
Approval Number
国药准字H35020008
Approval Date
Jan 3, 2024
NMPA

Homoharringtonine Injection

Product Name
高三尖杉酯碱注射液
Approval Number
国药准字H20033671
Approval Date
Nov 23, 2023
NMPA

Tobramycin Sulfate Injection

Product Name
硫酸妥布霉素注射液
Approval Number
国药准字H35020015
Approval Date
Nov 23, 2023
NMPA

Methionine and Vitamin B1 Injection

Product Name
甲硫氨酸维B1注射液
Approval Number
国药准字H20064114
Approval Date
Aug 4, 2021
NMPA

Raceanisodamine Hydrochloride Injection

Product Name
盐酸消旋山茛菪碱注射液
Approval Number
国药准字H35020011
Approval Date
Aug 11, 2020
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H35021354
Approval Date
Jul 28, 2020
NMPA

Ribavirin Injection

Product Name
利巴韦林注射液
Approval Number
国药准字H35020016
Approval Date
Jul 28, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.